← Eichor
Condition: Meningococcal Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Meningococcal

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Immunogenicity and Safety of MenB Vaccine in Pediatric Patients With Autoimmune Rheumatic Diseases
Phase 4 · 2 location(s) · University of Sao Paulo General Hospital · NCT07252804Assessment of Immunogenicity, Reactogenicity and Safety of the Drug GNG-DE in Comparison With the Reference Drug
Phase 3 · 17 location(s) · NPO Petrovax · NCT06834100National Bacterial Meningitis Study in Children and Newborns
Phase N/A · 1 location(s) · Association Clinique Thérapeutique Infantile du val de Marne · NCT04664569Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons
Phase 4 · 1 location(s) · University Ghent · NCT06832514Immunogenicity and Safety of Meningococcal Conjugate Vaccine (EG-MCV4) in Healthy Adults Aged 19 to 55 Years Old
Phase 2/Phase 3 · 1 location(s) · EyeGene Inc. · NCT07204457A Phase I Clinical Trial to Assess the Safety and Immunogenicity of DX-104
Phase 1 · 1 location(s) · Shanghai Yuguan Biotech Co., Ltd.（Delonix Bioworks) · NCT07395739Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV
Phase 4 · 1 location(s) · Thomas Benfield · NCT04875819Meningococcal B Vaccine in Patients with Asplenia
Phase 2 · 1 location(s) · Medical University of Vienna · NCT06025487Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135
Phase 1 · 1 location(s) · CanSino Biologics Inc. · NCT07203755Evaluation of the Antibody Persistence Beyond Five Years After Immunization With MenFiveTM (NmCV-5), a Pentavalent Menin
Phase N/A · 2 location(s) · Serum Institute of India Pvt. Ltd. · NCT07379151Observational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to MenQuadfi® Du
Phase N/A · 1 location(s) · Sanofi Pasteur, a Sanofi Company · NCT04843111Research Trial Assessing the Immunogenicity and Safety of Three Meningococcal B Vaccine Strategies Among Patients With A
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04166656
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.